DealsBaxter International to divest BioPharma Solutions business to Advent and Warburg Pincus for $4.2bnThe deal is expected to close in the second half of 2023.ByIris Dorbian8 May 2023•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs